Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Sigleceem1/Cya
Common Name:
Siglece-KO
Product ID:
S-KO-15370
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Siglece-KO
Strain ID
KOCMP-83382-Siglece-B6J-VA
Gene Name
Siglece
Product ID
S-KO-15370
Gene Alias
Cd170; Siglec12; Siglec5; Siglec9; Siglecl1; mSiglec-E
Background
C57BL/6JCya
NCBI ID
83382
Modification
Conventional knockout
Chromosome
7
Phenotype
MGI:1932475
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Sigleceem1/Cya mice (Catalog S-KO-15370) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000032667
NCBI RefSeq
NM_031181
Target Region
Exon 1~7
Size of Effective Region
~8.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Siglec-E, also known as sialic acid-binding immunoglobulin-like lectin E, is an important immune-regulatory receptor. It belongs to the Siglec family and binds to sialic acid-containing glycans. Siglec-E is involved in immune-related pathways, regulating immune cell activation and immune responses, which is of great biological significance in maintaining immune homeostasis [2,3,4,5,6,7,8]. Gene knockout mouse models have been crucial for studying its functions.

In glioblastoma, deletion of Siglec-E (murine homolog of Siglec-9) led to restrained tumor development and prolonged survival. It directly activated CD4+ and CD8+ T cells through antigen presentation, chemokine secretion, and co-stimulatory factor interactions, and synergized with anti-PD-1/PD-L1 treatment to enhance antitumor efficacy [1]. In multiple murine cancer models, Siglec-E knockout in myeloid cells prolonged survival and increased tumor infiltration of activated T cells, indicating its role in modulating anticancer immunity [8]. In meta-inflammation and metabolic disorder, inactivation of the CD24-Siglec-E pathway exacerbated diet-induced metabolic disorders, while CD24Fc treatment alleviated them, suggesting its role in suppressing obesity-related metabolic dysfunction [5].

In conclusion, Siglec-E plays a significant role in immune regulation and is involved in various disease conditions such as cancer and metabolic disorders. Studies using Siglec-E knockout mouse models have revealed its functions in tumor growth regulation, immune cell activation, and metabolic disease modulation, providing valuable insights for potential therapeutic strategies in these disease areas.

References:

1. Mei, Yan, Wang, Xiumei, Zhang, Ji, Chen, Jun, Jia, Guangshuai. 2023. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. In Nature cancer, 4, 1273-1291. doi:10.1038/s43018-023-00598-9. https://pubmed.ncbi.nlm.nih.gov/37460871/

2. Stanczak, Michal A, Rodrigues Mantuano, Natalia, Kirchhammer, Nicole, Zippelius, Alfred, Läubli, Heinz. 2022. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. In Science translational medicine, 14, eabj1270. doi:10.1126/scitranslmed.abj1270. https://pubmed.ncbi.nlm.nih.gov/36322632/

3. Gray, Melissa A, Stanczak, Michal A, Mantuano, Natália R, Läubli, Heinz, Bertozzi, Carolyn R. 2020. Targeted glycan degradation potentiates the anticancer immune response in vivo. In Nature chemical biology, 16, 1376-1384. doi:10.1038/s41589-020-0622-x. https://pubmed.ncbi.nlm.nih.gov/32807964/

4. Smith, Benjamin A H, Deutzmann, Anja, Correa, Kristina M, Felsher, Dean W, Bertozzi, Carolyn R. 2023. MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2215376120. doi:10.1073/pnas.2215376120. https://pubmed.ncbi.nlm.nih.gov/36897988/

5. Wang, Xu, Liu, Mingyue, Zhang, Jifeng, Zheng, Pan, Liu, Yang. . CD24-Siglec axis is an innate immune checkpoint against metaflammation and metabolic disorder. In Cell metabolism, 34, 1088-1103.e6. doi:10.1016/j.cmet.2022.07.005. https://pubmed.ncbi.nlm.nih.gov/35921817/

6. Schmassmann, Philip, Roux, Julien, Buck, Alicia, Läubli, Heinz, Hutter, Gregor. 2023. Targeting the Siglec-sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma. In Science translational medicine, 15, eadf5302. doi:10.1126/scitranslmed.adf5302. https://pubmed.ncbi.nlm.nih.gov/37467314/

7. Liao, Chaoxiong, Luo, Shuhua, Liu, Xiaolei, Ma, Daqing, Tang, Jing. 2024. Siglec-F+ neutrophils in the spleen induce immunosuppression following acute infection. In Theranostics, 14, 2589-2604. doi:10.7150/thno.93812. https://pubmed.ncbi.nlm.nih.gov/38646647/

8. Wieboldt, Ronja, Sandholzer, Michael, Carlini, Emanuele, Läubli, Heinz, Mantuano, Natalia Rodrigues. 2024. Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2. In Cellular & molecular immunology, 21, 495-509. doi:10.1038/s41423-024-01142-0. https://pubmed.ncbi.nlm.nih.gov/38448555/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest